Morgan Lewis Advises ZEPHYRx in Sale to Clinical Research Organization

BOSTON, August 18, 2026 – Morgan Lewis represented ZEPHYRx, a provider of respiratory endpoint data capture and monitoring solutions for clinical trials and clinical care, in the company’s sale to a health information technology and clinical research company.

The company’s mission is to advance respiratory clinical research by integrating respiratory endpoints, patient data, and trial operations to support data quality, improve trial execution, and help advance the development of new therapies.

Morgan Lewis partners Shannon Zollo and Meghan Kelly as well as associates Francesca Oliveira Considine and Blaine Milton advised ZEPHYRx with partners Meghan McCarthy, Jeanna Gunville, David Zelikoff, Joshua French, and associates Emily Jordan, Tom Turgeon, Claire Lesikar, Roshni Edalur, Emily Coury, and Kiran Jassal.